Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid

被引:100
作者
Kolb, SA
Lahrtz, F
Paul, R
Leppert, D
Nadal, D
Pfister, HW
Fontana, A
机构
[1] Univ Zurich Hosp, Dept Internal Med, Clin Immunol Sect, CH-8044 Zurich, Switzerland
[2] Univ Munich, Klinikum Grosshadern, Dept Neurol, D-8000 Munich, Germany
[3] Univ Hosp, Dept Res & Neurol, Basel, Switzerland
[4] Univ Zurich, Childrens Hosp, Infect Dis Unit, CH-8032 Zurich, Switzerland
关键词
viral meningitis; metalloproteinase; gelatinase A and B; metalloproteinase inhibitor; central nervous system; blood-brain barrier; zymography;
D O I
10.1016/S0165-5728(97)00247-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A hallmark of viral meningitis is the invasion of monocytes, lymphocytes and, in the initial phase of the disease, neutrophils into the subarachnoidal space. By their degradation of different macromolecular components in the extracellular connective tissue, matrix metalloproteinases (MMPs) may be essential for the breakdown of the vessel wall in the meninges and the choroid plexus. In this study, the occurrence of MMP-1, MMP-2, MMP-3 and MMP-9 and the two tissue inhibitors of metalloproteinases, TIMP-1 and TIMP-2, was monitored in the cerebrospinal fluid (CSF) from patients with viral meningitis. Of the proteinases, MMP-9 was found in 13 of 39 (33%) patients, but not in controls; the levels being correlated with the neutrophil cell number in CSF. The CSF concentration of TIMP-1 was increased three-fold compared to the control group (median 233 ng/ml; range 9.4-1252.5 ng/ml) and was correlated to the levels of total protein in CSF. Of the other MMPs and TIMPs assayed, MMP-2 and TIMP-2 were constitutively expressed and not upregulated in viral meningitis. High levels of MMP-9 and MMP-2, as measured by ELISA, was associated with high proteolytic activity detected in CSF by zymography. In conclusion, invasion of the leukocytes into the CSF compartment in viral meningitis may involve MMP-9, its proteolytic effect likely being controlled by expression of TIMP-1. (C) 1998 Elsevier Science B.V.
引用
收藏
页码:143 / 150
页数:8
相关论文
共 40 条
  • [1] BACKSTROM JR, 1995, J NEUROCHEM, V64, P1312
  • [2] Backstrom JR, 1996, J NEUROSCI, V16, P7910
  • [3] The AP-1 site and MMP gene regulation: What is all the fuss about?
    Benbow, U
    Brinckerhoff, CE
    [J]. MATRIX BIOLOGY, 1997, 15 (8-9) : 519 - 526
  • [4] BIRKEDAL HH, 1993, J PERIODONTOL, P500
  • [5] MATRIX METALLOPROTEINASES - A REVIEW
    BIRKEDALHANSEN, H
    MOORE, WGI
    BODDEN, MK
    WINDSOR, LJ
    BIRKEDALHANSEN, B
    DECARLO, A
    ENGLER, JA
    [J]. CRITICAL REVIEWS IN ORAL BIOLOGY & MEDICINE, 1993, 4 (02) : 197 - 250
  • [6] Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3
    Brooks, PC
    Stromblad, S
    Sanders, LC
    vonSchalscha, TL
    Aimes, RT
    StetlerStevenson, WG
    Quigley, JP
    Cheresh, DA
    [J]. CELL, 1996, 85 (05) : 683 - 693
  • [7] Matrix metalloproteinases degrade myelin basic protein
    Chandler, S
    Coates, R
    Gearing, A
    Lury, J
    Wells, G
    Bone, E
    [J]. NEUROSCIENCE LETTERS, 1995, 201 (03) : 223 - 226
  • [8] Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-alpha inhibitor
    Clements, JM
    Cossins, JA
    Wells, GMA
    Corkill, DJ
    Helfrich, K
    Wood, LM
    Pigott, R
    Stabler, G
    Ward, GA
    Gearing, AJH
    Miller, KM
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1997, 74 (1-2) : 85 - 94
  • [9] The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
    Cuzner, ML
    Gveric, D
    Strand, C
    Loughlin, AJ
    Paemen, L
    Opdenakker, G
    Newcombe, J
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (12) : 1194 - 1204
  • [10] DELAISSE JM, 1993, J CELL SCI, V106, P1071